HK1073245A1 - Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases - Google Patents

Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases

Info

Publication number
HK1073245A1
HK1073245A1 HK05105850.3A HK05105850A HK1073245A1 HK 1073245 A1 HK1073245 A1 HK 1073245A1 HK 05105850 A HK05105850 A HK 05105850A HK 1073245 A1 HK1073245 A1 HK 1073245A1
Authority
HK
Hong Kong
Prior art keywords
derivatives
diseases
substituted phenyl
obesity
treatment
Prior art date
Application number
HK05105850.3A
Other languages
English (en)
Inventor
Jochen Antel
Harald Waldeck
Andreas Potthoff
Sabine Irmer
Gregory Peter-Colin
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of HK1073245A1 publication Critical patent/HK1073245A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Communicable Diseases (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK05105850.3A 2001-07-18 2005-07-11 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases HK1073245A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10135027A DE10135027A1 (de) 2001-07-18 2001-07-18 Verwendung Trifluoracetylalkyl-substituierter Phenyl-, Phenol- und Benzoylderivate in der Behandlung und/oder Prophylaxe von Obestias und deren Begleit- und/oder Folgeerkrankungen
PCT/EP2002/007782 WO2003007923A2 (de) 2001-07-18 2002-07-12 Verwendung von trifluoracetylalkyl-substituierte phenyl-, phenol- und benzoylderivate in der behandlung und/oder prophylaxe von obesitas und deren begleit- und/oder folgeerkrankungen

Publications (1)

Publication Number Publication Date
HK1073245A1 true HK1073245A1 (en) 2005-09-30

Family

ID=7692273

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05105850.3A HK1073245A1 (en) 2001-07-18 2005-07-11 Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases

Country Status (13)

Country Link
US (1) US6930207B2 (pt)
EP (1) EP1420771B9 (pt)
JP (1) JP4511172B2 (pt)
CN (1) CN1596106B (pt)
AT (1) ATE338542T1 (pt)
AU (1) AU2002328884B8 (pt)
BR (1) BR0211196A (pt)
CA (1) CA2455483C (pt)
DE (2) DE10135027A1 (pt)
HK (1) HK1073245A1 (pt)
MX (1) MXPA04000325A (pt)
PL (1) PL216996B1 (pt)
WO (1) WO2003007923A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101009472B1 (ko) * 2001-06-12 2011-01-19 웰스테트 테라퓨틱스 코포레이션 대사 질환의 치료용 화합물
EP1601251B1 (en) * 2003-02-13 2014-11-12 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
RU2530889C2 (ru) * 2004-05-14 2014-10-20 Эмисфире Текнолоджис, Инк. Соединения и составы для доставки активных веществ
KR100733516B1 (ko) 2005-09-29 2007-06-29 노키아 코포레이션 네트워크 기반 서비스들을 중개하는 네트워크 서비스 제공장치, 휴대용 전자 장치, 시스템 및 방법
WO2008013963A2 (en) 2006-07-28 2008-01-31 University Of Connecticut Fatty acid amide hydrolase inhibitors
US20080221105A1 (en) * 2007-01-29 2008-09-11 Arete Therapeutics, Inc. Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders
WO2008122119A1 (en) * 2007-04-05 2008-10-16 The Royal Institution For The Advancement Of Learning/Mcgill University Perfluoroketone compounds and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3046300A (en) * 1960-10-21 1962-07-24 Merck & Co Inc alpha-trifluoromethyloxyphenylalanines
ZA714221B (en) * 1970-07-10 1972-03-29 Astra Ab Insecticides
US4051223A (en) * 1975-11-10 1977-09-27 General Mills Chemicals, Inc. Process for the recovery of magnesium
DE2918775A1 (de) * 1979-05-10 1980-11-20 Merck Patent Gmbh Diketone, verfahren zu ihrer herstellung und ihre verwendung als komponenten fluessigkristalliner dielektrika
US4408077A (en) * 1981-11-13 1983-10-04 Ayerst, Mckeena & Harrison, Inc. 6-(Lower alkoxy)-5-(trifluoromethyl)-1-naphthalenecarboxaldehydes
US4917826A (en) * 1985-10-18 1990-04-17 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
WO1988008002A1 (en) * 1987-04-16 1988-10-20 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
FR2614725B1 (fr) * 1987-04-28 1992-10-30 Rhone Poulenc Chimie Procede d'elimination de la radioactivite d'effluents par extraction liquide-liquide
FR2623798B1 (fr) * 1987-11-26 1990-05-04 Lucien Laboratoires Derives de trifluoromethyl-1 tetralines, leur preparation et leur application pour la synthese de composes presentant des proprietes therapeutiques
US4962024A (en) * 1988-08-11 1990-10-09 Becton, Dickinson And Company Signal enhancement in assay for an enzyme
FR2701259B1 (fr) * 1993-02-08 1995-03-24 Rhone Poulenc Agrochimie Procédé pour la préparation de dérivés phénylbenzamides fongicides agricoles.
CZ294630B6 (cs) * 1993-11-30 2005-02-16 G. D. Searle & Co. Substituované pyrazolylbenzensulfonamidy pro léčení zánětů
DE19649093A1 (de) * 1996-11-27 1998-05-28 Bayer Ag Mikrobizide Mittel auf Basis von Thiophen-2-carbonsäure-Derivaten
WO1999015129A2 (en) * 1997-09-23 1999-04-01 Bristol-Myers Squibb Company SELECTIVE cPLA2 INHIBITORS
GB9900416D0 (en) * 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
GB9910378D0 (en) * 1999-05-05 1999-06-30 Smithkline Beecham Plc Novel compounds
EA200200520A1 (ru) * 1999-12-03 2002-10-31 Пфайзер Продактс Инк. Производные гетероциклоалкилсульфонилпиразола в качестве противовоспалительных/анальгетических агентов
ATE234299T1 (de) * 1999-12-03 2003-03-15 Pfizer Prod Inc Sulfamoylheteroarylpyrazolverbindungen zur verwendung als analgetisches/entzündungshemmendes mittel
TR200001872A2 (tr) * 2000-06-26 2002-01-21 Fako �La�Lari A.� 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine ilişkin yöntem.
US20020103192A1 (en) * 2000-10-26 2002-08-01 Curtin Michael L. Inhibitors of histone deacetylase

Also Published As

Publication number Publication date
WO2003007923A2 (de) 2003-01-30
DE50208081D1 (de) 2006-10-19
EP1420771B1 (de) 2006-09-06
PL366933A1 (en) 2005-02-07
EP1420771B9 (de) 2007-10-17
CN1596106A (zh) 2005-03-16
US20040214901A1 (en) 2004-10-28
ATE338542T1 (de) 2006-09-15
AU2002328884B2 (en) 2008-02-07
JP2005500329A (ja) 2005-01-06
EP1420771A2 (de) 2004-05-26
CA2455483A1 (en) 2003-01-30
DE10135027A1 (de) 2003-02-06
US6930207B2 (en) 2005-08-16
CA2455483C (en) 2012-01-24
JP4511172B2 (ja) 2010-07-28
PL216996B1 (pl) 2014-06-30
AU2002328884B8 (en) 2008-06-26
CN1596106B (zh) 2011-05-11
WO2003007923A3 (de) 2004-01-08
MXPA04000325A (es) 2005-03-07
BR0211196A (pt) 2004-10-26

Similar Documents

Publication Publication Date Title
HK1073245A1 (en) Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
TW200608979A (en) Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
IL151313A0 (en) Lipase containing pharmaceutical compositions
NO20025601L (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
IL157652A (en) Metalloproteinase inhibitors, compositions comprising them and uses thereof for the preparation of medicaments for treating diseases or conditions mediated by metalloproteinase enzymes
MY151199A (en) Substituted diphenyl heterocycles useful for treating hcv infection
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
DE60036961D1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1-piperazinpentanamide als hiv-proteasehemmer
JO2373B1 (en) W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
SE9800836D0 (sv) New Compounds
TW200508214A (en) Novel compounds
MXPA03008045A (es) Nuevas composiciones de medicamentos en base a agentes anticolinergicos e inhibidores de pde-iv.
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
MXPA05012675A (es) Compuestos de hidroxiamidina e hidroxiguanidina como inhibidores de urocinasa.
MXPA04005809A (es) Inhibidores de proteinas quinasas.
DK1355906T3 (da) 2H-1-benzopyranderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger indeholdende dem
IL137489A0 (en) Pharmaceutical compositions containing inhibitors of the lymphotoxin pathway
HU0102159D0 (en) Pharmaceutical composition for the treatment of rumen acidosis
IL140768A0 (en) Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
MXPA03004023A (es) Compuestos quimicos.
GB9930768D0 (en) Composition
AU2002328884A1 (en) Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary diseases
AU2001265876A1 (en) Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150712